BASIS OF PRESENTATION AND SUMMARY OF ACCOUNTING POLICIES - Additional information (Details)						3 Months Ended				6 Months Ended		12 Months Ended
	Jan. 13, 2021 USD ($) $ / shares shares	Dec. 10, 2020 USD ($)	Oct. 07, 2020 USD ($)	Sep. 30, 2020 USD ($) $ / shares	May 01, 2020 USD ($)	Mar. 31, 2021 USD ($) customer $ / shares shares	Dec. 31, 2020 USD ($) customer	Mar. 31, 2020 USD ($)	Dec. 31, 2019 USD ($) customer	Mar. 31, 2021 USD ($) customer $ / shares	Mar. 31, 2020 USD ($)	Sep. 30, 2020 USD ($) customer $ / shares
Concentration Risk [Line Items]
Retained Earnings (Accumulated Deficit)				$ (269,835,650)		$ (276,162,006)				$ (276,162,006)		$ (269,835,650)
Net loss						(1,517,078)	$ (4,807,062)	$ (2,950,905)	$ (2,662,741)	(6,324,140)	$ (5,613,646)
Negative operating cash flow										7,426,015	5,151,404
Cash and cash equivalents				$ 7,786,743		13,925,997				13,925,997		$ 7,786,743
Working Capital Surplus Deficit						$ 15,289,055				$ 15,289,055
Common Stock, Par Or Stated Value Per Share | $ / shares				$ 0.001		$ 0.001				$ 0.001		$ 0.001
Research and development						$ 874,055		$ 703,018		$ 1,622,420	1,267,444
Allowance on accounts receivable (in dollars)				$ 11,968		20,830				20,830		$ 11,968
Depreciation method							straight-line method
Property, Plant and Equipment, Net				1,277,655		2,422,628				2,422,628		1,277,655
Net proceeds from exercise of warrants		$ 1,100,000								2,613,929	$ 2,768,133
Excess of FDIC insurance limit				7,300,000		$ 13,308,000				13,308,000		7,300,000
PPP Loan
Concentration Risk [Line Items]
Proceeds from Issuance of Debt					$ 847,000
Public Offering
Concentration Risk [Line Items]
Number of common stock issued | shares	1,810,000
Public offering price for each share together with warrant | $ / shares	$ 8.30
Number of warrants exercised | shares						520,151
Net proceeds from exercise of warrants			$ 1,669,500			$ 2,600,000
Net proceeds of offering after underwriter discounts, commissions and other offering expenses	$ 13,800,000
Computer equipment
Concentration Risk [Line Items]
Estimated useful life for computer equipment, lab equipment and furniture						P3Y
Construction in progress				$ 785,541		$ 646,140				646,140		$ 785,541
Lab equipment
Concentration Risk [Line Items]
Estimated useful life for computer equipment, lab equipment and furniture						P3Y
Property, Plant and Equipment, Net						$ 269,095				269,095
Furniture
Concentration Risk [Line Items]
Estimated useful life for computer equipment, lab equipment and furniture						P3Y
Leasehold improvements
Concentration Risk [Line Items]
Lease revenue						$ 89,447				$ 141,016
Two customer
Concentration Risk [Line Items]
Concentration risk percentage						30.00%
Total Revenue
Concentration Risk [Line Items]
Number of customers | customer							2		4
Total Revenue | One customer
Concentration Risk [Line Items]
Concentration risk percentage									12.00%
Total Revenue | Two customer
Concentration Risk [Line Items]
Concentration risk percentage						19.00%			14.00%
Total Revenue | Three customers
Concentration Risk [Line Items]
Concentration risk percentage						18.00%			21.00%
Accounts Receivable | Three customers
Concentration Risk [Line Items]
Concentration risk percentage						65.00%
Number of customers | customer						2
Accounts Receivable | Four customer
Concentration Risk [Line Items]
Concentration risk percentage				74.00%
Number of customers | customer												4
Customer Concentration Risk | Two customer
Concentration Risk [Line Items]
Concentration risk percentage						21.00%				29.00%
Number of customers | customer										2
Customer Concentration Risk | Total Revenue | Two customer
Concentration Risk [Line Items]
Concentration risk percentage										16.00%
Customer Concentration Risk | Total Revenue | Three customers
Concentration Risk [Line Items]
Concentration risk percentage						18.00%		19.00%
Customer Concentration Risk | Total Revenue | Four customer
Concentration Risk [Line Items]
Concentration risk percentage											10.00%